Skip to main content
Clinical Trials/NCT05485701
NCT05485701
Recruiting
N/A

Perinatal Mental Health Study (PMHS): a Cohort and Validation Study in Two Low-income Settings in India

University of Oxford2 sites in 1 country2,332 target enrollmentSeptember 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
University of Oxford
Enrollment
2332
Locations
2
Primary Endpoint
Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.

Detailed Description

The purpose of this observational study is to assess the mental health of perinatal women living in two low-income settings in India. The first phase will explore women's awareness of mental illness and acceptability of screening for mental disorders. The second phase will be a validation study, during which the psychometric properties of screening tools will be assessed against a gold standard. The third stage will comprise a cohort study, during which the prevalence of and risk factors for mental disorders among perinatal and non-perinatal women will be established.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
August 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • For Phase 1 (qualitative study) and Phase 2 (validation study):
  • Pregnant women:
  • Aged 18 to 45 years
  • Currently pregnant (any trimester)
  • Willing and able to give informed consent
  • Post-partum women:
  • Aged 18 to 45 years
  • Currently post-partum (between 1-12 months postpartum)
  • Willing and able to give informed consent
  • Non-perinatal women:

Exclusion Criteria

  • The participant may not enter the study if:
  • They have an acutely severe psychiatric illness which impairs their ability to take part in the study
  • They are not willing or able to provide informed consent
  • Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.

Outcomes

Primary Outcomes

Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women

Time Frame: September 2023 - August 2024

During the cohort study, risk factors associated with mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.

Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disorders

Time Frame: To be completed by August 2022

These will be themes emerging from focus groups with women around awareness of perinatal mental disorders and acceptability of screening.

Phase 2: Psychometric properties of screening tools for common mental disorders

Time Frame: September 2022 - August 2023

The psychometric properties (sensitivity, specificity, area under the receiver operating curve, optimal cut-off and accuracy) of eight screening tools in Kannada and Hindi will be established among three groups of women: pregnant, post-partum and non-perinatal.

Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal women

Time Frame: September 2023 - August 2024

During the cohort study, prevalence and incidence of mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.

Study Sites (2)

Loading locations...

Similar Trials